389 related articles for article (PubMed ID: 19822881)
1. Review article: high-throughput affinity-based technologies for small-molecule drug discovery.
Zhu Z; Cuozzo J
J Biomol Screen; 2009 Dec; 14(10):1157-64. PubMed ID: 19822881
[TBL] [Abstract][Full Text] [Related]
2. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
Bergsdorf C; Ottl J
Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
[TBL] [Abstract][Full Text] [Related]
3. Fragment screening using X-ray crystallography.
Davies TG; Tickle IJ
Top Curr Chem; 2012; 317():33-59. PubMed ID: 21678136
[TBL] [Abstract][Full Text] [Related]
4. High-throughput screening for modulators of protein-protein interactions: use of photonic crystal biosensors and complementary technologies.
Heeres JT; Hergenrother PJ
Chem Soc Rev; 2011 Aug; 40(8):4398-410. PubMed ID: 21140010
[TBL] [Abstract][Full Text] [Related]
5. Revolution of Small Molecule Drug Discovery by Affinity Selection-Mass Spectrometry Technology.
Motoyaji T
Chem Pharm Bull (Tokyo); 2020; 68(3):191-193. PubMed ID: 32115525
[TBL] [Abstract][Full Text] [Related]
6. [Fragment-based lead discovery from smaller fragments to functional ligand].
Hatayama A; Habashita H
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1611-6. PubMed ID: 21089596
[No Abstract] [Full Text] [Related]
7. Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.
Hennig M; Ruf A; Huber W
Top Curr Chem; 2012; 317():115-43. PubMed ID: 21837555
[TBL] [Abstract][Full Text] [Related]
8. Screening methods for influenza antiviral drug discovery.
Atkins C; Evans CW; White EL; Noah JW
Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
[TBL] [Abstract][Full Text] [Related]
9. Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.
Gul S; Hadian K
Expert Opin Drug Discov; 2014 Dec; 9(12):1393-404. PubMed ID: 25374163
[TBL] [Abstract][Full Text] [Related]
10. Solid-phase biological assays for drug discovery.
Forsberg EM; Sicard C; Brennan JD
Annu Rev Anal Chem (Palo Alto Calif); 2014; 7():337-59. PubMed ID: 25000820
[TBL] [Abstract][Full Text] [Related]
11. Cheminformatics approaches to analyze diversity in compound screening libraries.
Akella LB; DeCaprio D
Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
[TBL] [Abstract][Full Text] [Related]
12. Natural product libraries: assembly, maintenance, and screening.
Butler MS; Fontaine F; Cooper MA
Planta Med; 2014 Sep; 80(14):1161-70. PubMed ID: 24310213
[TBL] [Abstract][Full Text] [Related]
13. High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug-plasma protein interactions.
Vuignier K; Guillarme D; Veuthey JL; Carrupt PA; Schappler J
J Pharm Biomed Anal; 2013 Feb; 74():205-12. PubMed ID: 23245252
[TBL] [Abstract][Full Text] [Related]
14. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
[TBL] [Abstract][Full Text] [Related]
15. Applications of Biophysics in High-Throughput Screening Hit Validation.
Genick CC; Barlier D; Monna D; Brunner R; Bé C; Scheufler C; Ottl J
J Biomol Screen; 2014 Jun; 19(5):707-14. PubMed ID: 24695619
[TBL] [Abstract][Full Text] [Related]
16. An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives.
Leifer BS; Doyle SK; Richters A; Evans HL; Koehler AN
Methods Enzymol; 2018; 610():191-218. PubMed ID: 30390799
[TBL] [Abstract][Full Text] [Related]
17. Establish an automated flow injection ESI-MS method for the screening of fragment based libraries: Application to Hsp90.
Riccardi Sirtori F; Caronni D; Colombo M; Dalvit C; Paolucci M; Regazzoni L; Visco C; Fogliatto G
Eur J Pharm Sci; 2015 Aug; 76():83-94. PubMed ID: 25952103
[TBL] [Abstract][Full Text] [Related]
18. Development and utilization of activated STAT3 detection assays for screening a library of secreted proteins.
Fursov N; Gates IV; Panavas T; Giles-Komar J; Powers G
Assay Drug Dev Technol; 2011 Aug; 9(4):420-9. PubMed ID: 21294636
[TBL] [Abstract][Full Text] [Related]
19. Perspectives on the discovery of small-molecule modulators for epigenetic processes.
Lu Q; Quinn AM; Patel MP; Semus SF; Graves AP; Bandyopadhyay D; Pope AJ; Thrall SH
J Biomol Screen; 2012 Jun; 17(5):555-71. PubMed ID: 22392809
[TBL] [Abstract][Full Text] [Related]
20. Increasing the delivery of next generation therapeutics from high throughput screening libraries.
Wigglesworth MJ; Murray DC; Blackett CJ; Kossenjans M; Nissink JW
Curr Opin Chem Biol; 2015 Jun; 26():104-10. PubMed ID: 25909818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
